Physician profile
Ryan M Geringer
NPI 1699966044
$11,238.64
in general payments reported to CMS, 2019-2025
14 companies · $810 in 2025
The $810 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,127 · 2020: $41.46 · 2021: $482 · 2022: $3,937 · 2023: $4,416 · 2024: $426 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,386 · Food and Beverage: $1,266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,385.57 |
| Food and Beverage | $1,266.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cgg Medical INC | $9,128.46 | 2019-2025 | |
| Arthrex, INC. | $739.43 | 2019-2025 | |
| Stryker Corporation | $519.28 | 2021-2025 | Mako, Aequalis Perform Reversed, Tornier Perform Reversed Glenoid |
| Horizon Therapeutics Plc | $292.92 | 2019-2021 | |
| Depuy Synthes Sales INC. | $160.35 | 2022 | |
| Paragon 28, INC. | $143.92 | 2021 | |
| Medtronic, INC. | $69.33 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $66.75 | 2019-2024 | Exparel |
| Bioventus LLC | $29.50 | 2022 | |
| Avanos Medical | $25.32 | 2019 | |
| Amgen INC. | $23.09 | 2019 | |
| Organogenesis INC. | $16.58 | 2019 | |
| Next Science LLC | $11.95 | 2020 | |
| Smith+Nephew, INC. | $11.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Geringer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.